Sigma Planning Corp Coll Plant Biotechnologies LTD Transaction History
Sigma Planning Corp
- $3.32 Billion
- Q3 2025
Shares
3 transactions
Others Institutions Holding CLGN
# of Institutions
21Shares Held
2.74MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC589KShares$1.13 Million0.16% of portfolio
-
Pinnacle Associates LTD507KShares$973,8100.01% of portfolio
-
Investment Management Of Virginia LLC464KShares$890,6860.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$530,7452.69% of portfolio
-
Heights Capital Management, Inc San Francisco, CA275KShares$528,1570.1% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $21.3M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...